Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Detectable concentrations of Fas ligand in cerebrospinal fluid after severe head injury.
Ertel W, Keel M, Stocker R, Imhof HG, Leist M, Steckholzer U, Tanaka M, Trentz O, Nagata S. Ertel W, et al. J Neuroimmunol. 1997 Dec;80(1-2):93-6. doi: 10.1016/s0165-5728(97)00139-2. J Neuroimmunol. 1997. PMID: 9413263
In contrast, cerebrospinal fluid from patients with severe brain injury contained high concentrations of Fas ligand without detectable concentrations in serum. Soluble Fas ligand concentrations in …
In contrast, cerebrospinal fluid from patients with severe brain injury contained high concentrations of …
Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans.
Lenzlinger PM, Marx A, Trentz O, Kossmann T, Morganti-Kossmann MC. Lenzlinger PM, et al. J Neuroimmunol. 2002 Jan;122(1-2):167-74. doi: 10.1016/s0165-5728(01)00466-0. J Neuroimmunol. 2002. PMID: 11777556
Recent data suggest a role for Fas (APO-1, CD95), a type I transmembrane receptor glycoprotein of the nerve growth factor/tumor necrosis factor superfamily, and its ligand (Fas ligand, FasL) in apoptotic events in the central nervous system. ...Soluble …
Recent data suggest a role for Fas (APO-1, CD95), a type I transmembrane receptor glycoprotein of the nerve growth factor/tumor necro …
Feedback